Status:

Red

Decision Date:

September 2019

Comments

RED - Treatment of patients with cystic fibrosis (CF) aged ≥12 years who are homozygous for the F508del mutation or who are heterozygous for the F508del mutation.

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again